Simplex Trading’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.11M Buy
52,500
+40,300
+330% +$4.07M ﹤0.01% 1098
2025
Q4
$972K Buy
12,200
+2,200
+22% +$144K ﹤0.01% 2634
2025
Q3
$467K Buy
10,000
+5,200
+108% +$204K ﹤0.01% 3917
2025
Q2
$176K Sell
4,800
-100
-2% -$3.84K ﹤0.01% 4644
2025
Q1
$173K Sell
4,900
-5,100
-51% -$207K ﹤0.01% 4494
2024
Q4
$437K Sell
10,000
-27,700
-73% -$1.4M ﹤0.01% 3686
2024
Q3
$1.71M Buy
37,700
+12,100
+47% +$527K ﹤0.01% 2416
2024
Q2
$993K Buy
25,600
+19,300
+306% +$721K ﹤0.01% 2915
2024
Q1
$203K Sell
6,300
-6,200
-50% -$184K ﹤0.01% 4846
2023
Q4
$358K Sell
12,500
-500
-4% -$12K ﹤0.01% 4042
2023
Q3
$359K Buy
13,000
+10,100
+348% +$300K ﹤0.01% 3744
2023
Q2
$77K Sell
2,900
-1,100
-28% -$27K ﹤0.01% 5374
2023
Q1
$86K Buy
+4,000
New +$98.5K ﹤0.01% 5320
2022
Q3
Sell
-100
Closed -$1K 10757
2022
Q2
$1K Sell
100
-1,100
-92% -$21.4K ﹤0.01% 9655
2022
Q1
$30K Sell
1,200
-1,300
-52% -$28.3K ﹤0.01% 7776
2021
Q4
$62K Buy
2,500
+2,300
+1,150% +$64.8K ﹤0.01% 6949
2021
Q3
$6K Hold
200
﹤0.01% 9220
2021
Q2
$6K Buy
+200
New +$6.98K ﹤0.01% 9396

Other funds holding RVMD

Simplex Trading's RVMD Position: Q1 2026 in Review

Simplex Trading sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 9,644 shares — an estimated $974K sold.

Simplex Trading first reported a position in RVMD in Q4 2020 and held it in 13 quarters. The position peaked at $768K in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Simplex Trading reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 9,644 Revolution Medicines shares in Q1 2026, an estimated $974K.
  • Simplex Trading first reported a position in Revolution Medicines in Q4 2020 and held it in 13 quarters.
  • Simplex Trading's Revolution Medicines position peaked at $768K in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.